DelSite files Chapter 7 bankruptcy protection
The company’s board of directors authorized the filing after extensive efforts to raise funds for its ongoing drug development operations and for its H5N1 bird flu clinical trial
Roche has received the US Food and Drug Administration (FDA) priority review for its supplemental biologics licence application (sBLA) for adjuvant Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) in combination with chemotherapy for colon cancer.
Tongjitang believes that Jingfang’s Fengshi Gutong and Jingshu products, in addition to Tongjitang’s Xianling Gubao and LLF’s Heiguteng, will further the company’s brand leadership in orthopedic-focused traditional Chinese